Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8603)
All Articles published online
|
Publishing Process of This Article
|
Oct 7, 2016 (publication date) through Jun 3, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Siddiqui MRS, Bhoday J, Battersby NJ, Chand M, West NP, Abulafi AM, Tekkis PP, Brown G. Defining response to radiotherapy in rectal cancer using magnetic resonance imaging and histopathological scales. World J Gastroenterol 2016; 22(37): 8414-8434 [PMID: 27729748 DOI: 10.3748/wjg.v22.i37.8414] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v22/i37/8414.htm |
| Number | Citing Articles |
| 1 |
T. P. Berezovskaia, Ya. A. Dayneko, A. A. Nevolskikh, S. A. Ivanov, A. D. Kaprin. Prospective Assessment of mrTRG System Used for Determining the Efficiency of Neoadjuvant Chemoradiotherapy in Patients with Rectal Cancer. Journal of radiology and nuclear medicine 2021; 102(1): 6 doi: 10.20862/0042-4676-2021-102-1-6-17
|
| 2 |
Camille Raets, Chaimae El Aisati, Mark De Ridder, Kurt Barbe. Radiomics for the prediction of the regression grade of colorectal cancer: a challenging classification problem. 2022 IEEE International Symposium on Medical Measurements and Applications (MeMeA) 2022; : 1 doi: 10.1109/MeMeA54994.2022.9856515
|
| 3 |
Jung Min Kim, Jung Won Park, Jin Ha Lee, Ye Hyun Park, Soo Jung Park, Jae Hee Cheon, Won Ho Kim, Tae Il Kim. Survival Benefit for Metformin Through Better Tumor Response by Neoadjuvant Concurrent Chemoradiotherapy in Rectal Cancer. Diseases of the Colon & Rectum 2020; 63(6): 758 doi: 10.1097/DCR.0000000000001624
|
| 4 |
Yankai Meng, Lijuan Wan, Feng Ye, Chongda Zhang, Shuangmei Zou, Xinming Zhao, Kai Xu, Hongmei Zhang, Chunwu Zhou. MRI morphologic and clinicopathologic characteristics for predicting outcomes in patients with locally advanced rectal cancer. Abdominal Radiology 2019; 44(11): 3652 doi: 10.1007/s00261-018-1828-1
|
| 5 |
Aleksandra Stanojevic, Jelena Spasic, Mladen Marinkovic, Suzana Stojanovic-Rundic, Radmila Jankovic, Ana Djuric, Jerome Zoidakis, Remond J. A. Fijneman, Sergi Castellvi-Bel, Milena Cavic. Methylenetetrahydrofolate reductase polymorphic variants C677T and A1298C in rectal cancer in Slavic population: significance for cancer risk and response to chemoradiotherapy. Frontiers in Genetics 2024; 14 doi: 10.3389/fgene.2023.1299599
|
| 6 |
Nicolás Luis Avellaneda, Sofía Akselrad, Julieta Grasselli, Marcelo Andrade Irusta, Daiana Figueroa, Ricardo Cobeñas, Germán Espil, Nicolás Roccatagliata, Augusto Carrie. How can I Start an Multidisciplinary Team for Management of Rectal Cancer Patients? Analysis of the Feasibility of Using American National Accreditation Program for Rectal Cancer Patients Standards in a Low-Income Country Hospital. Turkish Journal of Colorectal Disease 2022; 32(3): 186 doi: 10.4274/tjcd.galenos.2022.2021-11-8
|
| 7 |
Chongda Zhang, Feng Ye, Yuan Liu, Han Ouyang, Xinming Zhao, Hongmei Zhang. Morphologic predictors of pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer. Oncotarget 2018; 9(4): 4862 doi: 10.18632/oncotarget.23419
|
| 8 |
R. Glynne-Jones, L. Wyrwicz, E. Tiret, G. Brown, C. Rödel, A. Cervantes, D. Arnold. Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology 2017; 28: iv22 doi: 10.1093/annonc/mdx224
|
| 9 |
Deborah S. Keller, Gina Brown. Invited editorial re: “Response assessment after (chemo) radiotherapy for rectal cancer: Why are we missing complete responses with MRI and endoscopy?”. European Journal of Surgical Oncology 2019; 45(6): 929 doi: 10.1016/j.ejso.2018.12.013
|
| 10 |
Bengt Glimelius. On a prolonged interval between rectal cancer (chemo)radiotherapy and surgery. Upsala Journal of Medical Sciences 2017; 122(1): 1 doi: 10.1080/03009734.2016.1274806
|
| 11 |
Doenja M. J. Lambregts, Thierry N. Boellaard, Regina G. H. Beets-Tan. Response evaluation after neoadjuvant treatment for rectal cancer using modern MR imaging: a pictorial review. Insights into Imaging 2019; 10(1) doi: 10.1186/s13244-019-0706-x
|
| 12 |
Muhammed R. S. Siddiqui, Svetlana Balyansikova, Gina Brown. Comprehensive Rectal Cancer Care. 2019; : 39 doi: 10.1007/978-3-319-98902-0_3
|
| 13 |
Sena Azamat, Şule Karaman, Ibrahim Fethi Azamat, Gokhan Ertaş, Cemil Burak Kulle, Metin Keskin, Rabia Nergiz Dağoğlu Sakin, Barış Bakır, Ethem Nezih Oral, Merve Gulbiz Kartal. Complete Response Evaluation of Locally Advanced Rectal Cancer to
Neoadjuvant Chemoradiotherapy Using Textural Features Obtained from
T2 Weighted Imaging and ADC Maps. Current Medical Imaging Formerly Current Medical Imaging Reviews 2022; 18(10): 1061 doi: 10.2174/1573405618666220303111026
|
| 14 |
Linda Kokaine, Andris Gardovskis, Jānis Gardovskis. Evaluation and Predictive Factors of Complete Response in Rectal Cancer after Neoadjuvant Chemoradiation Therapy. Medicina 2021; 57(10): 1044 doi: 10.3390/medicina57101044
|
| 15 |
T. P. Berezoskaya, S. A. Mozerov, Ya. A. Dayneko, A. A. Nevolskikh, Z. N. Shavladze, S. A. Ivanov, A. D. Kaprin. MRI-PATHOLOGICAL PARALLELS WITH THE COMPLETE TUMOR RESPONSE TO NEOADJUVANT CHEMORADIATION TREATMENT OF RECTAL CANCER. Research'n Practical Medicine Journal 2019; 6(2): 40 doi: 10.17709/2409-2231-2019-6-2-4
|
| 16 |
Vetri Sudar Jayaprakasam, Janet Alvarez, Dana M. Omer, Marc J. Gollub, J. Joshua Smith, Iva Petkovska. Watch-and-Wait Approach to Rectal Cancer: The Role of Imaging. Radiology 2023; 307(1) doi: 10.1148/radiol.221529
|
| 17 |
Marco Rengo, Simona Picchia, Simona Marzi, Davide Bellini, Damiano Caruso, Mauro Caterino, Maria Ciolina, Domenico De Santis, Daniela Musio, Vincenzo Tombolini, Andrea Laghi. Magnetic resonance tumor regression grade (MR-TRG) to assess pathological complete response following neoadjuvant radiochemotherapy in locally advanced rectal cancer. Oncotarget 2017; 8(70): 114746 doi: 10.18632/oncotarget.21778
|
| 18 |
Giulio M. Mari, Pietro Achilli, Dario Maggioni, Jacopo Crippa, Andrea T.M. Costanzi, Mauro A. Scotti, Vittorio Giardini, Mattia Garancini, Eugenio Cocozza, Giacomo Borroni, Ilaria Benzoni, Mario Martinotti, Luigi Totaro, Matteo Origi, Michele Mazzola, Giovanni Ferrari, Antonio Ziccarelli, Roberto Petri, Vincenzo Bagnardi, Giacomo Pugliese, Antonello Forgione, Raffaele Pugliese. Creation of a rectal cancer registry in Italy by the Advanced International Mini-Invasive Surgery (AIMS) academy clinical research network. F1000Research 2019; 8: 1736 doi: 10.12688/f1000research.20702.1
|
| 19 |
Zhen Guan, Rui-Jia Sun, Wu-Teng Cao, Hong-Mei Zhang, Tao Yu, Xiao-Ping Yu, Jian-Xin Zhang, Xiao-Yan Zhang, Xiao-Ting Li, Zhi-Yang Zhou, Xin-Ming Zhao, Lu Wen, Ying-Shi Sun. Magnetic resonance imaging tumor response score (mrTRS) predicts therapeutic effect and prognosis of locally advanced rectal cancer after neoadjuvant chemoradiotherapy: A prospective, multi-center study. Radiotherapy and Oncology 2020; 151: 288 doi: 10.1016/j.radonc.2020.08.028
|
| 20 |
Stephanie Nougaret, Pascal Rousset, Doenja M.J. Lambregts, Monique Maas, Kirsten Gormly, Oliver Lucidarme, Serge Brunelle, Laurent Milot, Lionel Arrivé, Celine Salut, Franck Pilleul, Constance Hordonneau, Guillaume Baudin, Philippe Soyer, Vanessa Brun, Valérie Laurent, Celine Savoye-Collet, Iva Petkovska, Jean-Pierre Gerard, Eddy Cotte, Philippe Rouanet, Onofrio Catalano, Quentin Denost, Regina Beets Tan, Nora Frulio, Christine Hoeffel. MRI restaging of rectal cancer: The RAC (Response–Anal canal–CRM) analysis joint consensus guidelines of the GRERCAR and GRECCAR groups. Diagnostic and Interventional Imaging 2023; 104(7-8): 311 doi: 10.1016/j.diii.2023.02.002
|
| 21 |
Christina Fleming, Véronique Vendrely, Eric Rullier, Quentin Denost. Organ preservation in rectal cancer: review of contemporary management. British Journal of Surgery 2022; 109(8): 695 doi: 10.1093/bjs/znac140
|
| 22 |
Zhengwu Tan, Lan Cheng, Lingling Xie, Lan Zhang, Zhenyu Lin, Ping Han, Xin Li. Comparison of the diagnostic performance of changes in signal intensity and volume from multiparametric MRI for assessing response of rectal cancer to neoadjuvant chemoradiotherapy. Asia-Pacific Journal of Clinical Oncology 2023; 19(3): 327 doi: 10.1111/ajco.13878
|
| 23 |
Aparna N. Katdare, Akshay D. Baheti, Sayali Y. Pangarkar, Kunal A. Mistry, Suman K. Ankathi, Purvi D. Haria, Amit J. Choudhari, Amrita Guha, Kunal Gala, Nitin Shetty, Suyash Kulkarni, Mukta Ramadwar, Munita Bal. Evaluation of an Objective MRI-Based Tumor Regression Grade (mrTRG) Score and a Subjective Likert Score for Assessing Treatment Response in Locally Advanced Rectal Cancers—A Retrospective Study. Indian Journal of Radiology and Imaging 2024; 34(01): 69 doi: 10.1055/s-0043-1772695
|
| 24 |
Suvi Marjasuo, Laura Koskenvuo, Anna Lepistö. Findings in magnetic resonance imaging for restaging locally advanced rectal cancer. International Journal of Colorectal Disease 2024; 39(1) doi: 10.1007/s00384-024-04595-x
|
| 25 |
Francesco Sclafani, Gina Brown, David Cunningham, Andrew Wotherspoon, Larissa Sena Teixeira Mendes, Svetlana Balyasnikova, Jessica Evans, Clare Peckitt, Ruwaida Begum, Diana Tait, Josep Tabernero, Bengt Glimelius, Susana Roselló, Janet Thomas, Jacqui Oates, Ian Chau. Comparison between MRI and pathology in the assessment of tumour regression grade in rectal cancer. British Journal of Cancer 2017; 117(10): 1478 doi: 10.1038/bjc.2017.320
|
| 26 |
Camille Raets, Chaïmae El Aisati, Amir L. Rifi, Kurt Barbé, Mark De Ridder. Predicting the Response to Chemoradiotherapy in Rectal Cancer Patients Using Bayesian Evolutionary Random Forest and Three-Dimensional Discrete Fourier Transform. 2023 IEEE International Symposium on Medical Measurements and Applications (MeMeA) 2023; : 1 doi: 10.1109/MeMeA57477.2023.10171859
|
| 27 |
Pietro Achilli, Carmelo Magistro, Mohamed A. Abd El Aziz, Giacomo Calini, Camillo L. Bertoglio, Giovanni Ferrari, Giulio Mari, Dario Maggioni, Georgios Peros, Sara Tamburello, Elisabetta Coppola, Antonino Spinelli, Fabian Grass, David Martin, Dieter Hahnloser, Andrea Salvatori, Silvia De Simoni, Shannon P. Sheedy, Joel G. Fletcher, David W. Larson. Modest agreement between magnetic resonance and pathological tumor regression after neoadjuvant therapy for rectal cancer in the real world. International Journal of Cancer 2022; 151(1): 120 doi: 10.1002/ijc.33975
|
| 28 |
Yankai Meng, Lijuan Wan, Chongda Zhang, Chen Wang, Feng Ye, Shaodong Li, Shuangmei Zou, Jyh Cheng, Kai Xu, Chunwu Zhou, Hongmei Zhang. The Predictive Value of Pre-/Postneoadjuvant Chemoradiotherapy MRI Characteristics for Patient Outcomes in Locally Advanced Rectal Cancer. Academic Radiology 2020; 27(9): e233 doi: 10.1016/j.acra.2019.10.021
|
| 29 |
Rahma Boughriba, Ghada Sahraoui, Ines Chaar, Marwa Weslati, Khouloud Ayed, Donia Ounissi, Mariem Hazgui, Saadia Bouraoui, Asma Gati. Significant association of MCP1 rs1024611 and CCR2 rs1799864 polymorphisms with colorectal cancer and liver metastases susceptibility and aggressiveness: A case-control study. Cytokine 2023; 167: 156193 doi: 10.1016/j.cyto.2023.156193
|
| 30 |
Camille Raets, Chaïmae El Aisati, Mark De Ridder, Alexandra Sermeus, Kurt Barbé. An Evolutionary Random Forest to measure the Dworak tumor regression grade applied to colorectal cancer. Measurement 2022; 205: 112131 doi: 10.1016/j.measurement.2022.112131
|
| 31 |
Filippo Crimì, Giulia Capelli, Gaya Spolverato, Quoc Riccardo Bao, Anna Florio, Sebastiano Milite Rossi, Diego Cecchin, Laura Albertoni, Cristina Campi, Salvatore Pucciarelli, Roberto Stramare. MRI T2-weighted sequences-based texture analysis (TA) as a predictor of response to neoadjuvant chemo-radiotherapy (nCRT) in patients with locally advanced rectal cancer (LARC). La radiologia medica 2020; 125(12): 1216 doi: 10.1007/s11547-020-01215-w
|
| 32 |
Luis R. Taveras, Holly B. Cunningham, Jonathan B. Imran. Can We Reliably Predict a Clinical Complete Response in Rectal Cancer? Current Trends and Future Strategies. Current Colorectal Cancer Reports 2018; 14(2): 56 doi: 10.1007/s11888-018-0401-1
|
| 33 |
Lijuan Wan, Wenjing Peng, Shuangmei Zou, Feng Ye, Yayuan Geng, Han Ouyang, Xinming Zhao, Hongmei Zhang. MRI-based delta-radiomics are predictive of pathological complete response after neoadjuvant chemoradiotherapy in locally advanced rectal cancer. Academic Radiology 2021; 28: S95 doi: 10.1016/j.acra.2020.10.026
|
| 34 |
Mehdi Boubaddi, Christina Fleming, Veronique Vendrely, Nora Frulio, Cécile Salut, Eric Rullier, Quentin Denost. Feasibility study of a Response Surveillance Program in locally advanced mid and low rectal cancer to increase organ preservation. European Journal of Surgical Oncology 2023; 49(1): 237 doi: 10.1016/j.ejso.2022.08.031
|
| 35 |
Nir Stanietzky, Ajaykumar Morani, Venkateswar Surabhi, Corey Jensen, Natally Horvat, Raghu Vikram. Mucinous Rectal Adenocarcinoma—Challenges in Magnetic Resonance Imaging Interpretation. Journal of Computer Assisted Tomography 2024; doi: 10.1097/RCT.0000000000001599
|
| 36 |
Jia Gang Han, Zhen Jun Wang, Wei Gen Zeng, Yan Bin Wang, Guang Hui Wei, Zhi Wei Zhai, Bao Cheng Zhao, Bing Qiang Yi. Efficacy and safety of self-expanding metallic stent placement followed by neoadjuvant chemotherapy and scheduled surgery for treatment of obstructing left-sided colonic cancer. BMC Cancer 2020; 20(1) doi: 10.1186/s12885-020-6560-x
|
| 37 |
Marco Rengo, Federica Landolfi, Simona Picchia, Davide Bellini, Chiara Losquadro, Stefano Badia, Damiano Caruso, Elsa Iannicelli, Mattia Falchetto Osti, Vincenzo Tombolini, Iacopo Carbone, Gaetano Giunta, Andrea Laghi. Rectal cancer response to neoadjuvant chemoradiotherapy evaluated with MRI: Development and validation of a classification algorithm. European Journal of Radiology 2022; 147: 110146 doi: 10.1016/j.ejrad.2021.110146
|
| 38 |
Jeonghee Han, Jong Ho Kim, Jin-Won Lee, Sang Hyup Han, Haesung Kim. Neoadjuvant therapy of metformin is associated with good tumor response after preoperative concurrent chemoradiotherapy for rectal cancer. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-07768-2
|
| 39 |
Lei He, Juan Xiao, Ping Zheng, Lei Zhong, Qian Peng. Lymph node regression grading of locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy. World Journal of Gastrointestinal Oncology 2022; 14(8): 1429-1445 doi: 10.4251/wjgo.v14.i8.1429
|
| 40 |
Deborah S. Keller. Staging of Locally Advanced Rectal Cancer Beyond TME. Clinics in Colon and Rectal Surgery 2020; 33(05): 258 doi: 10.1055/s-0040-1713743
|
| 41 |
P. Yu. Grishko, A. V. Mishchenko, O. V. Ivko, D. V. Samsonov, A. M. Karachun. Treatment monitoring of locally advanced rectal cancer based on multiparametric magnetic resonance tomography. Pelvic Surgery and Oncology 2020; 10(1): 20 doi: 10.17650/2686-9594-2020-10-1-20-27
|
| 42 |
Camille Raets, Chaïmae El Aisati, Amir L. Rifi, Mark De Ridder, Koen Putman, Johan De Mey, Alexandra Sermeus, Kurt Barbé. Optimizing Rectal Cancer Patient Care: Dworak TRG Prediction via Bayesian Evolutionary Fourier-Domain Random Subspace Forest. IEEE Transactions on Instrumentation and Measurement 2024; 73: 1 doi: 10.1109/TIM.2024.3365163
|
| 43 |
Pavel Yu. Grishko, A. V. Mishchenko, O. V. Ivko, D. V. Samsonov, A. M. Karachun. Possibilities of multi-parametric magnetic resonance tomography in the assessment of neoadjuvant treatment of rectal cancer. Diagnostic radiology and radiotherapy 2020; (4): 49 doi: 10.22328/2079-5343-2019-10-4-49-56
|